Abstract: A doorframe fastening for a folding door comprises a doorframe profiled section (1), which has a securing limb (2) and a door leaf suspension (3). The doorframe fastening reliably withstands high weight loads and reduces noise emission but still allows a long-term use while avoiding cold bridges and damage from corrosion. An inner support limb (7) protrudes from the securing limb (2), said inner support limb being connected to an outer support limb (9) via a thermally insulating separating web (8), and the door leaf suspension (3) is supported both on the inner (7) as well as on the outer support limb (9).

Abstract: An installation and a method for treating a plastic melt includes a reactor that has a reactor housing consisting of first and second reactor housing parts, a mixing element being arranged in the second reactor housing part and mounted thereupon so as to rotate about a rotational axis. The reactor, together with a discharge device and with at least one weighing device connected between these, is supported on a contact area.

Abstract: An installation and a method for treating a plastic melt includes a reactor that has a reactor housing consisting of first and second reactor housing parts, a mixing element being arranged in the second reactor housing part and mounted thereupon so as to rotate about a rotational axis. The reactor, together with a discharge device and with at least one weighing device connected between these, is supported on a contact area.

Abstract: In a method and an apparatus for increasing the intrinsic viscosity of a polycondensate melt at negative pressure, the melt enters a chamber, in which a negative pressure of less than 20 mbar prevails, through a perforated plate or a screen having openings with a diameter of less than 0.5 mm. The melt passes through this chamber in free fall in thin threads and remains in a reservoir beneath the chamber for at least one minute. The melt is moved constantly in the reservoir, and discharged from the reservoir, by a helical mixing and discharge part.

Abstract: A sliding contact arrangement (13) is used in an erosion arrangement (10) or an erosion machine. The sliding contact arrangement (13) establishes an electrical connection with a slip ring (14), whereby said slip ring can be driven about a rotational axis (D), and with a current source or voltage source (11). The sliding contact arrangement (13) has an electrical connecting line (12) that can be electrically connected to the current source or voltage source (11). The connecting line (12) is mechanically and electrically connected to an electrically conductive body (20). On an underside (21) associated with the slip ring (14), the body (20) includes a plurality of projecting contact wires (35) bundled into several strands. In not loaded, not bent state, the strands (37) extend parallel to each other away from the underside (21) toward their free ends (39), which contact a common generated surface of a cylinder.

Abstract: In a method and an apparatus for increasing the intrinsic viscosity of a polycondensate melt at negative pressure, the melt enters a chamber, in which a negative pressure of less than 20 mbar prevails, through a perforated plate or a screen having openings with a diameter of less than 0.5 mm. The melt passes through this chamber in free fall in thin threads and remains in a reservoir beneath the chamber for at least one minute. The melt is moved constantly in the reservoir, and discharged from the reservoir, by a helical mixing and discharge part.

Abstract: A sliding contact arrangement (13) is used in an erosion arrangement (10) or an erosion machine. The sliding contact arrangement (13) establishes an electrical connection with a slip ring (14), whereby said slip ring can be driven about a rotational axis (D), and with a current source or voltage source (11). The sliding contact arrangement (13) has an electrical connecting line (12) that can be electrically connected to the current source or voltage source (11). The connecting line (12) is mechanically and electrically connected to an electrically conductive body (20). On an underside (21) associated with the slip ring (14), the body (20) includes a plurality of projecting contact wires (35) bundled into several strands. In not loaded, not bent state, the strands (37) extend parallel to each other away from the underside (21) toward their free ends (39), which contact a common generated surface of a cylinder.

Abstract: The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.

Abstract: The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.

Abstract: The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.

Abstract: The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.

Abstract: The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.

Abstract: The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficacious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.

Abstract: The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.

Abstract: The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.

Abstract: The invention concerns pharmaceutical preparations that are stable on storage, which contain at least one diphosphonic acid and/or at least one physiologically acceptable salt of such an acid as the active substance.